granted
on 19 Nov 2024
Last Applicant/ Owned by
139 Main Street, Suite 500
Cambridge
MA
02142
Serial Number
97690153 filed on 23rd Nov 2022
Registration Number
N/A
Correspondent Address
Maury M. Tepper, III
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonar Read More
Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Anti-cancer preparations; Biological preparations for the treatment of cancer; Digestives for pharmaceutical purposes; Drug delivery agents in the form of a capsule, pill, or liquid that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of cancer, cystic fibrosis, heart disease, and AIDS; Medicinal infusions for treating Cancer, cystic fibrosis, heart disease, and AIDS; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for the treatment and prevention of Cancer, cystic fibrosis, heart disease, and AIDS; Pharmaceutical products for the prevention and treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Therapeutic pharmaceutical for the treatment of Cancer, cystic fibrosis, heart disease, and AIDS; Unit dose capsules sold empty for pharmaceutical use
N/A
N/A
No 97690153
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
19th Nov 2024 | SOU EXTENSION 2 GRANTED |
19th Nov 2024 | SOU EXTENSION 2 FILED |
19th Nov 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
19th Nov 2024 | SOU TEAS EXTENSION RECEIVED |
13th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
07th Jun 2024 | SOU EXTENSION 1 GRANTED |
07th Jun 2024 | SOU EXTENSION 1 FILED |
07th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
12th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
17th Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |